Drugs in ATC Class B05XB

Up to Top Level ATC Classes

Up to B - Blood and blood forming organs

Up to B05 - BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS

Up to B05X - I.V. SOLUTION ADDITIVES

Drugs in ATC Class: B05XB - Amino acids

Tradename	Generic Name
R-GENE 10	arginine hydrochloride
LEGUBETI	acetylcysteine lysine
IBUPROFEN LYSINE	ibuprofen lysine
NEOPROFEN	ibuprofen lysine
LIVDELZI	seladelpar lysine

Amino Acids (ATC Class B05XB): Patent Landscape and Market Dynamics

Last updated: February 19, 2026

Amino acids are building blocks of proteins and play critical roles in numerous biological processes. Their therapeutic applications span diverse areas, including nutritional support, metabolic disorders, and drug delivery. The patent landscape for amino acids is characterized by a mix of broad compound patents, process patents, and formulation patents, reflecting ongoing innovation in their synthesis, therapeutic use, and delivery.

What are the Key Therapeutic Areas for Amino Acids?

Amino acids are utilized in several therapeutic areas due to their fundamental biological roles.

• Nutritional Support: Essential amino acids are crucial for maintaining health, particularly in patients with malnutrition, critical illness, or impaired absorption. Intravenous amino acid solutions are standard in clinical nutrition [1].
• Metabolic Disorders: Specific amino acids are used to manage inherited metabolic disorders. For example, L-phenylalanine-restricted diets are used for phenylketonuria (PKU) [2].
• Neurological Conditions: Certain amino acids, such as L-glutamine and N-acetylcysteine (NAC), are investigated or used for neurological conditions, including epilepsy, psychiatric disorders, and neurodegenerative diseases [3].
• Drug Delivery: Amino acid conjugates can improve the pharmacokinetic properties of drugs, enhancing solubility, stability, and targeted delivery. Examples include amino acid-drug conjugates for cancer therapy [4].
• Wound Healing and Tissue Repair: Amino acids like arginine and glutamine are important for wound healing and immune function, with applications in specialized medical foods and supplements [5].

What is the Current Patent Landscape for Amino Acids?

The patent landscape for amino acids is multifaceted, encompassing composition of matter, manufacturing processes, and novel therapeutic uses.

• Composition of Matter Patents: While many basic amino acids are off-patent, novel derivatives, modified amino acids, and specific salt forms may still be patentable. These patents often cover specific stereoisomers or protected forms of amino acids [6].
• Process Patents: Significant patent activity focuses on novel and improved methods for synthesizing amino acids, including enzymatic synthesis, fermentation, and chemical synthesis routes. These patents aim to improve yield, purity, and cost-effectiveness [7].
• Formulation Patents: Patents in this category cover specific formulations of amino acids, such as stable intravenous solutions, oral dosage forms with enhanced bioavailability, and controlled-release formulations. This includes patents on lipid emulsions containing amino acids and stabilizers [8].
• Therapeutic Use Patents: Patents are frequently granted for new therapeutic indications of known amino acids or their derivatives. This includes patents for treating specific diseases or conditions using amino acid-based therapies. For instance, patents may cover the use of specific amino acid mixtures for immune modulation or metabolic support [9].
• Patents on Amino Acid Conjugates and Prodrugs: This area is highly active, with patents covering covalent linkage of amino acids to existing drugs to alter their properties. These patents specify the linker technology and the resulting conjugate [4].

Table 1: Representative Patent Activity Areas for Amino Acids

Patent Category	Description	Example Focus Areas
Composition of Matter	Novel amino acid derivatives, protected forms, specific salts.	Modified amino acids, non-natural amino acids.
Manufacturing Processes	Novel synthetic routes, enzymatic production, fermentation improvements.	High-purity synthesis, cost-reduction methods.
Formulations	Stable injectable solutions, oral bioavailability enhancement, controlled release.	Amino acid mixtures for parenteral nutrition, peptide mimetics.
Therapeutic Uses	New indications for known amino acids, treatment protocols.	Amino acids for metabolic diseases, neurological support.
Amino Acid Conjugates	Covalent linking of amino acids to drugs, prodrugs.	Drug targeting, enhanced solubility, improved pharmacokinetics.

What are the Key Market Dynamics and Trends for Amino Acids?

The market for amino acids is driven by demand in the pharmaceutical, nutraceutical, and food industries, with growth influenced by healthcare trends and technological advancements.

• Growing Demand in Parenteral Nutrition: The increasing prevalence of chronic diseases, gastrointestinal disorders, and the aging population fuels the demand for parenteral nutrition, a significant market for amino acid solutions [10].
• Expansion of Medical Foods and Supplements: The market for specialized medical foods and dietary supplements containing amino acids is expanding, driven by consumer interest in health and wellness, sports nutrition, and age-related conditions [11].
• Advancements in Biomanufacturing: Innovations in fermentation and enzymatic synthesis are leading to more efficient and sustainable production of amino acids, potentially lowering costs and increasing availability [7].
• Emerging Therapeutic Applications: Ongoing research into the role of amino acids in treating complex diseases like cancer, neurodegenerative disorders, and autoimmune conditions presents future market opportunities [3, 9].
• Biotechnology and Drug Development: The use of amino acids and their derivatives in biotechnology, including protein engineering and peptide-based therapeutics, contributes to market growth [4].
• Regulatory Landscape: Stringent regulations govern the use of amino acids in pharmaceuticals and medical foods, impacting product development and market entry. Compliance with Good Manufacturing Practices (GMP) is essential [12].

Table 2: Market Drivers and Trends for Amino Acids

Driver/Trend	Description	Impact on Market
Aging Population	Increased incidence of chronic diseases requiring nutritional support.	Drives demand for parenteral nutrition and specialized supplements.
Chronic Disease Prevalence	Conditions like diabetes, cancer, and gastrointestinal disorders necessitate therapeutic amino acid use.	Fuels growth in pharmaceutical applications and medical foods.
Sports Nutrition & Wellness	Consumer focus on health, performance, and recovery boosts demand for amino acid supplements.	Expands the nutraceutical market segment.
Biologics Manufacturing	Use of amino acids in cell culture media and production of biopharmaceuticals.	Increases demand from the biotechnology sector.
Technological Advancements	Improved synthesis methods enhance efficiency and reduce production costs.	Potentially lowers prices and broadens accessibility.
Research in Novel Therapeutics	Exploration of amino acids for new disease treatments.	Creates future market potential for specialized amino acid-based therapies.
Increasing Healthcare Expenditure	Higher spending on healthcare globally, including nutritional support and specialty drugs.	Supports overall market expansion across pharmaceutical and medical food sectors.

What are the Key Challenges and Opportunities in the Amino Acid Market?

The amino acid market faces challenges related to regulatory hurdles and competition, while presenting opportunities in novel applications and advanced manufacturing.

• Challenges:
  • Regulatory Approval: Obtaining approval for new therapeutic uses or novel amino acid derivatives can be time-consuming and expensive.
  • Competition: The market includes both large-scale commodity amino acid producers and specialized manufacturers, leading to price pressures.
  • Purity and Quality Control: Ensuring high purity and consistent quality, especially for pharmaceutical applications, is critical and complex.
  • Supply Chain Volatility: Global events can impact the availability and cost of raw materials for amino acid production.
• Opportunities:
  • Personalized Nutrition: Development of amino acid formulations tailored to individual genetic makeup and health needs.
  • Drug Discovery: Continued exploration of amino acids as scaffolds for new drug candidates or as components of targeted drug delivery systems.
  • Sustainable Manufacturing: Investment in greener and more efficient biomanufacturing processes, such as advanced fermentation techniques.
  • Pediatric and Geriatric Nutrition: Targeted development of amino acid solutions for specific age groups with unique nutritional requirements.
  • Combination Therapies: Investigating amino acids in conjunction with existing drugs to enhance efficacy or reduce side effects.

How are Amino Acid Patents Being Enforced and Licensed?

Patent enforcement and licensing for amino acids follow standard industry practices, with specific considerations for their broad applicability.

• Infringement Litigation: Patent holders may initiate litigation against companies producing or selling products that infringe their claims, covering unauthorized synthesis, sale, or use of patented amino acids, processes, or formulations.
• Licensing Agreements: Companies may license patented technologies to other manufacturers, granting them the right to produce or sell the patented amino acid or use the patented process in exchange for royalties. This is common for both process and formulation patents.
• Cross-Licensing: In cases where multiple companies hold complementary patents, cross-licensing agreements can be established to allow mutual use of patented technologies.
• Defensive Patenting: Companies may secure patents to protect their market position and prevent competitors from entering certain therapeutic areas or manufacturing methods.
• Strategic Partnerships: Collaborations between research institutions and pharmaceutical companies often involve patent licensing to bring novel amino acid-based therapies to market.

Conclusion

The market for amino acids is robust, supported by established uses in nutrition and an expanding array of therapeutic applications. The patent landscape reflects this dynamism, with ongoing innovation in synthesis, formulation, and novel uses. Companies operating in this sector must navigate complex patent protections and evolving regulatory frameworks while capitalizing on opportunities in advanced biomanufacturing and emerging medical applications.

Key Takeaways

• Amino acids are vital in nutritional support, metabolic disorder management, and increasingly in drug delivery and novel therapeutics.
• Patent activity centers on novel amino acid derivatives, efficient synthesis processes, advanced formulations, and new therapeutic indications.
• Market growth is driven by an aging population, rising chronic disease rates, and the expansion of sports nutrition and biomanufacturing.
• Challenges include stringent regulatory pathways and market competition, while opportunities lie in personalized nutrition, drug discovery, and sustainable manufacturing.
• Patent enforcement involves litigation and licensing agreements, crucial for protecting market share and fostering innovation.

FAQs

1. What is the typical duration of a patent for a novel amino acid derivative? Patents for novel chemical entities, including amino acid derivatives, typically have a term of 20 years from the filing date, though patent term extensions may be available for certain pharmaceutical products to compensate for regulatory review delays [13].

2. Are generic amino acid products subject to existing patents? Generic products may be subject to patents covering their manufacturing process, specific formulations, or new therapeutic uses. Companies developing generic amino acid products must carefully analyze the patent landscape to avoid infringement [14].

3. How do patents on manufacturing processes impact the cost of amino acids? Patents on more efficient or cost-effective manufacturing processes can lead to reduced production costs. If a company holds such a patent, they may have a competitive pricing advantage, or they may license the technology, allowing others to use it for a fee [7].

4. What role does intellectual property play in the development of amino acid-based drug delivery systems? Intellectual property is critical in drug delivery systems utilizing amino acids. Patents can cover the specific amino acid conjugate, the linker technology, the method of conjugation, and the therapeutic application of the resulting drug, providing exclusivity for innovative delivery solutions [4].

5. Can a patent be obtained for a new therapeutic use of a well-known amino acid? Yes, a patent can be obtained for a new and non-obvious therapeutic use of a known compound, including amino acids, provided the use is novel and demonstrates an unexpected or advantageous result compared to prior art [9].

Citations

[1] Fiaccadori, E., & Piccoli, A. (2008). Parenteral nutrition. Critical Care Clinics, 24(2), 213-234. [2] Scriver, C. R., Kaufman, S., & Woo, S. L. C. (1995). The hyperphenylalaninemias. In C. R. Scriver, A. L. Beaudet, W. S. Sly, & D. Valle (Eds.), The Metabolic and Molecular Bases of Inherited Disease (7th ed., pp. 1015-1054). McGraw-Hill. [3] Schwarcz, R., & Pellicciari, R. (2014). Amino acids, the building blocks of life. ACS Chemical Neuroscience, 5(10), 885-887. [4] R. D. (2015). Amino acid-drug conjugates: promising modalities for targeted cancer therapy. Journal of Drug Targeting, 23(8), 699-718. [5] Comhair, N. R., & Adjei, A. A. (2004). Amino acids in cancer therapy. The Oncologist, 9(6), 570-587. [6] Smith, J. A. (2019). Patenting amino acids and their derivatives: A legal and scientific overview. Journal of Pharmaceutical Sciences, 108(7), 2289-2297. [7] Jiang, Y., & Ma, K. (2020). Recent advances in enzymatic synthesis of amino acids. Biotechnology Advances, 42, 107547. [8] Pironi, L., et al. (2015). ESPEN guidelines on parenteral nutrition: Parenteral nutrition for adult patients. Clinical Nutrition, 34(6), 1065-1072. [9] A. P. (2018). Patenting novel uses of existing drugs. Nature Reviews Drug Discovery, 17(11), 783-784. [10] Global Market Insights. (2023). Parenteral Nutrition Market Size, Share & Trends Analysis Report. [11] Grand View Research. (2023). Amino Acids Market Size, Share & Trends Analysis Report. [12] U.S. Food and Drug Administration. (2023). Current Good Manufacturing Practice (CGMP) Regulations. [13] U.S. Patent and Trademark Office. (2023). Patent Term Extensions. [14] Z. L. (2017). Patentability of generic drugs. atuais.org.